Search research articles
Contact Us
Filters
Showing results (151-160 of 333) with videos related to
Page
of 34
Sort By:
Human Reproduction (Oxford, England)
|
March 1, 2005
Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical study
H Stoop, F Honecker, M Cools, et al.
European Journal of Medical Research
|
July 2, 2011
Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trial
Marcus Schlemmer, S Bauer, R Schütte, et al.
Oncology
|
July 15, 1998
Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study
J T Hartmann, C H Köhne, H J Schmoll, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 13, 1998
Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastases
J T Hartmann, E Schmoll, C Bokemeyer, et al.
Der Urologe. Ausg. A
|
July 6, 2006
[Testicular tumor--yesterday--today--tomorrow]
S Krege, C Wittekind, R Souchon, et al.
Oncology Reports
|
December 29, 1998
Analysis of the cyclin-dependent kinase inhibitor p27Kip1 in muscle invasive bladder cancer
J Serth, M Kuczyk, S Machtens, et al.
British Journal of Cancer
|
January 1, 1995
p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder
J Serth, M A Kuczyk, C Bokemeyer, et al.
Pathology, Research and Practice
|
November 1, 1994
Overexpression of the p53 oncoprotein in carcinoma in situ of the testis
M A Kuczyk, J Serth, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 15, 2006
A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)
C Kollmannsberger, M Schittenhelm, F Honecker, et al.
Investigational New Drugs
|
July 27, 2012
A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer
J T Hartmann, C Kollmannsberger, I Cascorbi, et al.
Page
of 34
Search research articles
Search
Showing results (151-160 of 333) with videos related to
Sort By:
Page
of 34
Human Reproduction (Oxford, England)
|
March 1, 2005
Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical study
H Stoop, F Honecker, M Cools, et al.
European Journal of Medical Research
|
July 2, 2011
Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a German multicenter trial
Marcus Schlemmer, S Bauer, R Schütte, et al.
Oncology
|
July 15, 1998
Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study
J T Hartmann, C H Köhne, H J Schmoll, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 13, 1998
Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastases
J T Hartmann, E Schmoll, C Bokemeyer, et al.
Der Urologe. Ausg. A
|
July 6, 2006
[Testicular tumor--yesterday--today--tomorrow]
S Krege, C Wittekind, R Souchon, et al.
Oncology Reports
|
December 29, 1998
Analysis of the cyclin-dependent kinase inhibitor p27Kip1 in muscle invasive bladder cancer
J Serth, M Kuczyk, S Machtens, et al.
British Journal of Cancer
|
January 1, 1995
p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder
J Serth, M A Kuczyk, C Bokemeyer, et al.
Pathology, Research and Practice
|
November 1, 1994
Overexpression of the p53 oncoprotein in carcinoma in situ of the testis
M A Kuczyk, J Serth, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 15, 2006
A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)
C Kollmannsberger, M Schittenhelm, F Honecker, et al.
Investigational New Drugs
|
July 27, 2012
A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancer
J T Hartmann, C Kollmannsberger, I Cascorbi, et al.
Page
of 34